Stay updated on MRTX1719 in Solid Tumors With MTAP Deletion Clinical Trial
Sign up to get notified when there's something new on the MRTX1719 in Solid Tumors With MTAP Deletion Clinical Trial page.

Latest updates to the MRTX1719 in Solid Tumors With MTAP Deletion Clinical Trial page
- Check7 days agoChange DetectedNew locations have been added (Mineola, NY – Site 129; UNC Chapel Hill) and the total number of locations is now 25, with the Mineola site listed as Not yet Recruiting. The Houston, TX site and the Medical College of Wisconsin – Froedtert Hospital have been removed.SummaryDifference2%

- Check14 days agoNo Change Detected
- Check21 days agoChange DetectedRevision: v3.3.2 is displayed, replacing Revision: v3.2.0.SummaryDifference0.0%

- Check28 days agoChange DetectedPhase 1/1B dose escalation and Phase 1b Sub-studies 1-4 plus Sub-study 5 were added, with MRTX1719 as the intervention on specified days. Enrollment updated to 336 and key study dates (primary and study completion) set to 2027-12-10, with new documents and IPD sharing information (CSR, SAP, IPD sharing URL) added.SummaryDifference2%

- Check43 days agoChange DetectedNo significant changes to the study details; only non-critical metadata such as the last update timestamp appears updated, while core data like enrollment, primary endpoints, and eligibility criteria remain unchanged. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.3%

- Check71 days agoChange DetectedAdded a government-operating-status notice and updated version to v3.2.0; removed reference to v3.1.0.SummaryDifference4%

- Check79 days agoChange DetectedAdded multiple contact phone numbers and updated software revision to v3.1.0; removed previous revision v3.0.2.SummaryDifference0.1%

Stay in the know with updates to MRTX1719 in Solid Tumors With MTAP Deletion Clinical Trial
Enter your email address, and we'll notify you when there's something new on the MRTX1719 in Solid Tumors With MTAP Deletion Clinical Trial page.